logo

For the Inventor, By the Inventor

Halle (Saale), Germany

Probiodrug Ag


USPTO Granted Patents = 71



Forward Citations = 853

Loading Chart...
Loading Chart...

54 inventors (with patents filed for the assignee):

goldMedal Hans-Ulrich Demuth (53 out of 66 patents)

silverMedal Ulrich Heiser (44 out of 55 patents)

bronzeMedal Stephan Schilling (29 out of 32 patents)

4.  Torsten Hoffmann (20 out of 29 patents)

5.  Mirko Buchholz (19 out of 23 patents)

6.  Andre Johannes Niestroj (17 out of 19 patents)

7.  Jens-Ulrich Rahfeld (16 out of 18 patents)

8.  Daniel Ramsbeck (10 out of 13 patents)

9.  Robert Sommer (8 out of 9 patents)

10.  Holger Cynis (8 out of 10 patents)

11.  Martin Kleinschmidt (7 out of 8 patents)

12.  Michael Thormann (6 out of 17 patents)

13.  Andreas Treml (6 out of 14 patents)

14.  Livia Boehme (6 out of 6 patents)

15.  Sonja Kampfer (5 out of 5 patents)


Core Competencies:
Humanized Antibodies
Glutaminyl Cyclase Inhibitors
Diagnostic Antibody Assay
Transgenic Mouse Models
Amyloid-Beta Peptides
Inflammatory Diseases
Neurodegenerative Diseases
Enzyme Inhibitors
Crystal Structure Analysis
Pyroglutamate Modified Proteins
Knock-Out Mutation Models
Therapeutic Compounds

71 patents:

1. 11045533 - Humanized antibodies (2021-06-29),
2. 10603367 - Humanized antibodies (2020-03-31),
3. 9676843 - Uses of antibodies directed against amyloid-β (2017-06-13),
4. 9657089 - Diagnostic antibody assay (2017-05-23),
5. 9656991 - Inhibitors of glutaminyl cyclase (2017-05-23),
6. 9650362 - Inhibitors (2017-05-16),
7. 9610368 - Radiolabelled glutaminyl cyclase (QC) inhibitors and uses of same (2017-04-04),
8. 9512115 - Inhibitors (2016-12-06),
9. 9512082 - Inhibitors of glutaminyl cyclase (2016-12-06),
10. 9462793 - Mouse carrying a knock-out mutation of the Qpct-gene (2016-10-11),
11. 9277737 - Mouse models carrying a knock-out mutation of the QPCTL-gene (2016-03-08),
12. 9181233 - Inhibitors of glutaminyl cyclase (2015-11-10),
13. 9173885 - Inhibitors (2015-11-03),
14. 9157918 - Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE) (2015-10-13),
15. 9156907 - Diagnostic antibody assay (2015-10-13),
PROBIODRUG AG is a biopharmaceutical company that specializes in the development of innovative drug candidates for the treatment of diseases with high unmet medical needs. With a focus on targeting the extracellular proteome, the company aims to discover and develop novel therapeutics with improved efficacy and safety profiles. PROBIODRUG AG employs cutting-edge technologies and a deep understanding of human biology to identify and validate drug targets, enabling the development of groundbreaking therapies. For more information, please visit their website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

71 Patents

#1 in

#817 in

#10,081 in the World

...
Halle (Saale), Germany

Probiodrug Ag

Forward Citations = 853

54 inventors:

goldMedal Hans-Ulrich Demuth (53 out of 66 patents)

silverMedal Ulrich Heiser (44 out of 55 patents)

bronzeMedal Stephan Schilling (29 out of 32 patents)

4.  Torsten Hoffmann (20 out of 29 patents)

5.  Mirko Buchholz (19 out of 23 patents)

Please report any incorrect information to support@idiyas.com
Loading…